| Eileen Cole Harms, | |
|
10 Wing Shell Ln, Hilton Head Island, SC 29926-1902 | |
| (716) 672-9640 | |
| Not Available |
| Full Name | Eileen Cole Harms |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10 Wing Shell Ln, Hilton Head Island, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891952966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 008401 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eileen Cole Harms, 10 Wing Shell Ln, Hilton Head Island, SC 29926-1902 Ph: (716) 672-9640 | Eileen Cole Harms, 10 Wing Shell Ln, Hilton Head Island, SC 29926-1902 Ph: (716) 672-9640 |
News Archive
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.
OSI Pharmaceuticals, Inc. announced today that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing Tarceva (erlotinib) as an adjuvant therapy in patients with Stage IB-IIIA non-small cell lung cancer who have undergone surgery and have EGFR-positive tumors.
Sharply increased demand for artemether-lumefantrine, an artemisinin-based combination therapy (ACT) used to treat malaria, is likely to result in a shortage from now until at least March 2005. ACTs are currently the most effective medicines available to treat falciparum malaria - the deadliest form of the disease.
New research from the University of Oxford and the UK Centre for Ecology & Hydrology, published today in Frontiers in Public Health, uses mathematical modeling to determine the most equitable way to share vaccines between nations.
Profectus BioSciences, a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, and the AIDS Clinical Trials Group announced today the initiation of a phase 1 study of Profectus' multi-antigen HIV plasmid DNA vaccine administered with various doses of GENEVAX™ interleukin-12 pDNA adjuvant and delivered using the electroporation based TriGrid™delivery system developed by Ichor Medical Systems.
› Verified 6 days ago
Mrs. Ashley Cubbage, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1536 Fording Island Rd Ste 105, Hilton Head Island, SC 29926 Phone: 240-418-8864 Fax: 843-837-2081 | |
Madison Laurynn Vicendese, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1536 Fording Island Rd, Hilton Head Island, SC 29926 Phone: 843-837-2080 | |
Jessi Lee Fustos, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Sara Ct, Hilton Head Island, SC 29926 Phone: 732-762-5572 | |
Sierra Pool, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1536 Fording Island Rd Ste 105, Hilton Head Island, SC 29926 Phone: 843-837-2080 | |
Dr. Mary Ann Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Woodhaven Dr, Seabrook, Hilton Head Island, SC 29928 Phone: 843-842-3747 Fax: 843-842-3739 | |
Now We're Talking Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1536 Fording Island Rd Ste 105, Hilton Head Island, SC 29926 Phone: 843-837-2080 Fax: 843-837-2081 | |
Allison Thatcher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1536 Fording Island Rd Ste 105, Hilton Head Island, SC 29926 Phone: 843-837-2080 |